| IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia TY Zhang, R Dutta, B Benard, F Zhao, R Yin, R Majeti Science translational medicine 12 (538), eaax5104, 2020 | 57 | 2020 |
| Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia BA Benard, LB Leak, A Azizi, D Thomas, AJ Gentles, R Majeti Nature Communications 12 (1), 7244, 2021 | 38 | 2021 |
| Data mining for mutation-specific targets in acute myeloid leukemia B Benard, AJ Gentles, T Köhnke, R Majeti, D Thomas Leukemia 33 (4), 826-843, 2019 | 19 | 2019 |
| Genomic basis of multiple myeloma subtypes from the MMRF CoMMpass study S Skerget, D Penaherrera, A Chari, S Jagannath, DS Siegel, R Vij, ... Medrxiv, 2021.08. 02.21261211, 2021 | 16 | 2021 |
| Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia MA Bassal, SE Samaraweera, K Lim, BA Benard, S Bailey, S Kaur, P Leo, ... Nature communications 13 (1), 2614, 2022 | 13 | 2022 |
| FGFR3 mutations are an adverse prognostic factor in patients with t (4; 14)(p16; q32) multiple myeloma: an Mmrf commpass analysis B Benard, A Christofferson, C Legendre, J Aldrich, S Nasser, J Yesil, ... Blood 130, 3027, 2017 | 12 | 2017 |
| Integrative analysis of the genomic landscape underlying multiple myeloma at diagnosis: an Mmrf Commpass Analysis A Christofferson, S Nasser, J Aldrich, D Penaherrera, C Legendre, ... Blood 130, 326, 2017 | 7 | 2017 |
| A molecular analysis of cereblon-related immunomodulatory drug resistance in CoMMpass multiple myeloma patients S Skerget, B Benard, A Christofferson, C Legendre, J Aldrich, S Nasser, ... Blood 130, 1754, 2017 | 5 | 2017 |
| Distinct assemblies of heterodimeric cytokine receptors govern stemness programs in leukemia WL Kan, U Dhagat, KB Kaufmann, TR Hercus, TL Nero, AGX Zeng, ... Cancer Discovery 13 (8), 1922-1947, 2023 | 4 | 2023 |
| Comprehensive identification of fusion transcripts in multiple myeloma: an Mmrf commpass analysis S Nasser, A Christofferson, C Legendre, J Aldrich, B Benard, ... Blood 130, 61, 2017 | 4 | 2017 |
| Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity M Schwede, K Jahn, J Kuipers, LA Miles, RL Bowman, T Robinson, ... Leukemia, 1-10, 2024 | 2 | 2024 |
| Predicting response to new drugs in AML from simulation modelling: Value of the BEAT AML project as a validation resource. B Benard, D Thomas Leukemia Research 80, 43-44, 2019 | 1 | 2019 |
| Clonal Diversity of a Myeloma Tumor: From Generations of Cells to Treatment Implications K Stephenson, B Benard, M Klug, A Christofferson, JJ Keats Blood 124 (21), 3424, 2014 | 1 | 2014 |
| Integrating Features of Clonal Evolution in the Modeling of Disease Risk and Drug Sensitivity in Acute Myeloid Leukemia BA Benard Stanford University, 2023 | | 2023 |
| Clonal Architecture and Variant Allele Frequency Predict Clinical Outcomes and Drug Response in Acute Myeloid Leukemia B Benard, L Leak, A Azizi, D Thomas, A Gentles, R Majeti Blood 136, 2, 2020 | | 2020 |
| Reliability of Myeloma Model Systems: KP-6 Is a Novel Hyperdiploid Cell Line BA Benard, RC Tschumper, DK Walters, K Stephenson, DF Jelinek, ... Blood 128 (22), 3279, 2016 | | 2016 |
| Assessing the Evolutionary Divergence Between Four Multiple Myeloma Patient Tumors and Their Established Cell Lines BA Benard | | 2016 |
